Cohort study finds glucocorticoids increase risk of anxiety, depression

A population‐based cohort study using both self‐controlled and target trial emulation approaches has reported an association between use of oral glucocorticoids and increased risk of adverse psychiatric outcomes. Use of glucocorticoids was found to be associated with higher risk of depressive, bipolar, and anxiety disorders but did not increase risk of suicidality.